Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin

American Journal of Physiology - Endocrinology and Metabolism

Volumn 285, Issue 4 48-4, 2003, Pages

  Reisz Porszasz, Suzanne ^a   Bhasin, Shalender ^a   Artaza, Jorge N ^a   Shen, Ruoqing ^a   Sinha Hikim, Indrani ^a   Hogue, Aimee ^a   Fielder, Thomas J ^b   Gonzalez Cadavid, Nestor F ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Sarcopenia; Skeletal muscle growth; Wasting

Indexed keywords

COMPLEMENTARY DNA; CREATINE KINASE; DNA; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; MYOSTATIN; PROTEIN;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; FEMALE; GASTROCNEMIUS MUSCLE; GENDER; GENE MUTATION; GENE OVEREXPRESSION; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE GROWTH; MUSCLE MASS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUADRICEPS FEMORIS MUSCLE; SKELETAL MUSCLE; SOUTHERN BLOTTING; TIBIALIS ANTERIOR MUSCLE; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; TRANSGENIC MOUSE; WESTERN BLOTTING; WILD TYPE;

EID: 0141615887     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00107.2003     Document Type: Article

References (48)

1. Artaza JN, Bhasin S, Mallidis C, Taylor W, Ma K, and Gonzalez-Cadavid NF. Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells. J Cell Physiol 190: 170-179, 2002.
2. Carlson CJ, Booth FW, and Gordon SE. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol Regul Integr Comp Physiol 277: R601-R606, 1999.
3. Chalfie M, Tu Y, Euskirchen G, Ward WW, and Prasher DC. Green fluorescent protein as a marker for gene expression. Science 263: 802-805, 1994.
4. Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, Sinha-Hikim I, Ma K, Ezzat S, Shen R, Lalani R, Asa S, Mamita M, Nair G, Arver S, and Bhasin S. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci USA 95: 14938-14943, 1998.
5. Grobet L, Martin LJ, Poncelet D, Pirottin D, Brouwers B, Riquet J, Sehoeberlein A, Dunner S, Menissier F, Massabanda J, Fries R, Hanset R, and Georges M. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet 17: 71-74, 1997.
6. Grobet L, Poncelet D, Royo LJ, Brouwers B, Pirottin D, Michaux C, Menissier F, Zanotti M, Dunner S, and Georges M. Molecular definition of an allelic series of mutations disrupting the myostatin function and causing double-muscling in cattle. Mamm Genome 9: 210-213, 1998.
7. Grounds MD, White JD, Rosenthal N, and Bogoyevitch MA. The role of stem cells in skeletal and cardiac muscle repair. J Histochem Cytochem 50: 589-610, 2002.
8. Hogan B. Manipulating the Mouse Embryo: a Laboratory Manual. Plainview, NY: Cold Spring Harbor Laboratory, pp. xvii and 497, 1994.
9. Kahlert S, Grohe C, Karas RH, Lobbert K, Neyses L, and Vetter H. Effects of estrogen on skeletal myoblast growth. Biochem Biophys Res Commun 232: 373-378, 1997.
10. Kambadur R, Sharma M, Smith TP, and Bass JJ. Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res 7: 910-916, 1997.
11. Kirk S, Oldham J, Kambadur R, Sharma M, Dobbie P, and Bass J. Myostatin regulation during skeletal muscle regeneration. J Cell Physiol 184: 356-363, 2000.
12. Lalani R, Bhasin S, Byhower F, Tarnuzzer R, Grant M, Shen R, Asa S, Ezzat S, and Gonzalez-Cadavid NF. Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight. J Endocrinol 167: 417-428, 2000.
13. Lang CH, Silvis C, Nystrom G, and Frost RA. Regulation of myostatin by glucocorticoids after thermal injury. FASEB J 15: 1807-1809, 2001.
14. Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, and Kambadur R. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 277: 49831-49840, 2002.
15. Larochelle N, Lochmuller H, Zhao J, Jani A, Hallauer P, Hastings KE, Massie B, Prescott S, Petrof BJ, Karpati G, and Nalbantoglu J. Efficient muscle-specific transgene expression after adenovirus-mediated gene transfer in mice using a 1.35 kb muscle creatine kinase promoter/enhancer. Gene Ther 4: 465-472, 1997.
16. Lee SJ and McPherron AC. Myostatin and the control of skeletal muscle mass. Curr Opin Genet Dev 9: 604-607, 1999.
17. Lee SJ and McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 98: 9306-9311, 2001.
18. Lin J, Arnold HB, Della-Fera MA, Azain MJ, Hartzell DL, and Baile CA. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem Biophys Res Commun 291: 701-706, 2002.
19. Ma K, Mallidis C, Artaza J, Taylor W, Gonzalez-Cadavid N, and Bhasin S. Characterization of 5′-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. Am J Physiol Endocrinol Metab 281: E1128-E1136, 2001.
20. Ma K, Mallidis C, Bhasin S, Mahabadi V, Artaza J, Gonzalez-Cadavid N, and Salehian B. Glucocorticoid-induced muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab 285: E363-E371, 2003.
21. Marcell TJ, Harman SM, Urban RJ, Metz DD, Rodgers BD, and Blackman MR. Comparison of GH, IGF-I, and testosterone with mRNA of receptors and myostatin in skeletal muscle in older men. Am J Physiol Endocrinol Metab 281: E1159-E1164, 2001.
22. McMahon CD, Popovic L, Jeanplong F, Oldham JM, Kirk SP, Osepchook CC, Wong KW, Sharma M, Kambadur R, and Bass JJ. Sexual dimorphism is associated with decreased expression of processed myostatin in males. Am J Physiol Endocrinol Metab 284: E377-E381, 2003.
23. McPherron AC, Lawler AM, and Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387: 83-90, 1997.
24. McPherron AC and Lee SJ. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA 94: 12457-12461, 1997.
25. McPherron AC and Lee SJ. Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109: 595-601, 2002.
26. Michel U, Ebert S, Phillips D, and Nau R. Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia. Eur J Pharmacol 148: 559-564, 2003.
27. Nishi M, Yasue A, Nishimatu S, Nohno T, Yamaoka T, Itakura M, Moriyama K, Ohuchi H, and Noji S. A missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle. Biochem Biophys Res Commun 293: 247-251, 2002.
28. Reardon KA, Davis J, Kapsa RM, Choong P, and Byrne E. Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy. Muscle Nerve 24: 893-899, 2001.
29. Rios R, Carneiro I, Arce VM, and Devesa J. Myostatin regulates cell survival during C2C12 myogenesis. Biochem Biophys Res Commun 280: 561-566, 2001.
30. Rios R, Carneiro I, Arce VM, and Devesa J. Myostatin is an inhibitor of myogenic differentiation. Am J Physiol Cell Physiol 282: C993-C999, 2002.
31. Sakuma K, Watanabe K, Sano M, Uramoto I, and Totsuka T. Differential adaptation of growth and differentiation factor 8/myostatin, fibroblast growth factor 6 and leukemia inhibitory factor in overloaded, regenerating and denervated rat muscles. Biochim Biophys Acta 1497: 77-88, 2000.
32. Schiessl H, Frost HM, and Jee WS. Estrogen and bone-muscle strength and mass relationships. Bone 22: 1-6, 1998.
33. Schulte JN and Yarasheski KE. Effects of resistance training on the rate of muscle protein synthesis in frail elderly people. Int J Sport Nutr Exerc Metab 11, Suppl: S111-S118, 2001.
34. Sharma M, Kambadur R, Matthews KG, Somers WG, Devlin GP, Conaglen JV, Fowke PJ, and Bass JJ. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J Cell Physiol 180: 1-9, 1999.
35. Sharma M, Langley B, Bass J, and Kambadur R. Myostatin in muscle growth and repair. Exerc Sport Sci Rev 29: 155-158, 2001.
36. Shield MA, Haugen HS, Clegg CH, and Hauschka SD. E-box sites and a proximal regulatory region of the muscle creatine kinase gene differentially regulate expression in diverse skeletal muscles and cardiac muscle of transgenic mice. Mol Cell Biol 16: 5058-5068, 1996.
37. Sinha-Hikim I, Artaza J, Woodhouse L, Gonzalez-Cadavid N, Singh AB, Lee MI, Storer TW, Casaburi R, Shen R, and Bhasin S. Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab 283: E154-E164, 2002.
38. Szabo G, Dallmann G, Muller G, Patthy L, Soller M, and Varga L. A deletion in the myostatin gene causes the compact (Cmpt) hypermuscular mutation in mice. Mamm Genome 9: 671-672, 1998.
39. 12 muscle cells. Am J Physiol Endocrinol Metab 280: E221-E228, 2001.
40. Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J, and Kambadur R. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275: 40235-40243, 2000.
41. Tuuri T, Eramaa M, Hilden K, and Ritvos O. The tissue distribution of activin beta A- and beta B-subunit and follistatin messenger ribonucleic acid suggests multiple sites of action for the activin-follistatin system during human development. J Clin Endocrinol Metab 78: 1521-1524, 1994.
42. Wehling M, Cai B, and Tidball JG. Modulation of myostatin expression during modified muscle use. FASEB J 14: 103-110, 2000.
43. Yamanouchi K, Soeta C, Naito K, and Tojo H. Expression of myostatin gene in regenerating skeletal muscle of the rat and its localization. Biochem Biophys Res Commun 270: 510-516, 2000.
44. Yang J, Ratovitski T, Brady JP, Solomon MB, Wells KD, and Wall RJ. Expression of myostatin pro domain results in muscular transgenic mice. Mol Reprod Dev 60: 351-361, 2001.
45. Yarasheski KE, Bhasin S, Sinha-Hikim I, Pak-Loduca J, and Gonzalez-Cadavid NF. Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. J Nutr Health Aging 6: 343-348, 2002.
46. Zachwieja JJ, Smith SR, Sinha-Hikim I, Gonzalez-Cadavid N, and Bhasin S. Plasma myostatin-immunoreactive protein is increased after prolonged bed rest with low-dose T3 administration. J Gravit Physiol 6: 11-15, 1999.
47. Zhu X, Hadhazy M, Wehling M, Tidball JG, and McNally EM. Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Lett 474: 71-75, 2000.
48. Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, McPherron AC, Wolfman NM, and Lee SJ. Induction of cachexia in mice by systemically administered myostatin. Science 296: 1486-1488, 2002.